Back to Intellectual Property News
Bracewell Represents Syntrix in $96 Million DNA Patent Suit
Monday, March 18, 2013
Bracewell & Giuliani LLP won a federal jury verdict in a patent suit on behalf of Syntrix, a biotechnology research firm, against Illumina in the U.S. District Court for the Western District of Washington before U.S. District Judge Benjamin H. Settle.
Syntrix first filed the suit in November 2010, alleging that Illumina sales of its BeadChip products infringed U.S. Patent 6,951,682. After an 11 day trial, the jury awarded Syntrix $95,795,507 in damages and a 6 percent royalty rate.
Bracewell attorneys who worked on this matter include:
Partners: Alan D Albright and Michael R. Samardzija
Associates: Heather Khassian, Karthika Perumal, Christopher Schenck, and Lucy Tyson
Bracewell attorneys were also assisted by attorneys from Nix, Patterson & Roach: Derek Gilliland, Ed Chin, Andrew Wright, and Winn Cutler.
About Bracewell & Giuliani LLP
Bracewell & Giuliani LLP is an international law firm with 470 lawyers in Texas, New York, Washington, D.C., Connecticut, Seattle, Dubai, and London. We serve Fortune 500 companies, major financial institutions, leading private investment funds, governmental entities, and individuals concentrated in the infrastructure, energy, technology and financial services sectors worldwide. For more information, visit www.bgllp.com.
Back to Intellectual Property News
